www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
Business / Companies

Biotech boom, pride of Anhui

By Zhu Lixin (China Daily) Updated: 2016-07-19 08:14

Biotech boom, pride of Anhui

A bird's-eye view of the world's largest biotech drug production base in Hefei, Anhui province. The facility is shaped in the form of antibody ATCG. [Photo provided to China Daily]

Beijing-based Sinobioway Group Co Ltd, a major biotech company in China, is building the world's largest biotech drug production base at the Bantang township in Hefei, capital of Anhui province in East China.

The facility, shaped in the form of antibody ATCG and to be called the Bantang Bioeconomy Experimental Zone, will have 100 production lines to be completed in 10 to 15 years. The first five lines will be completed by the end of this year.

Work on another 10 will also start later this year, said Cao Wenbo, president of Anhui Sinobioway Bioeconomy Group, a subsidiary of Sinobioway Group.

The zone covers an area of 31 sq km. A 400,000-sq-meter plant is almost ready; the next two phases will take up 600,000 sq m.

Cao said infrastructure excluding the production lines will see an investment of 1.5 billion yuan ($224.3 million), which is being provided by the Hefei government.

Wu Cunrong, Party chief of Hefei city, said: "We believe the biotech drug sector will see enormous growth opportunities in future, so we will surely support such companies."

The company, Cao said, will repay the money in five years "so that we can have more money for mergers and acquisitions. We have enough money to reach the goal."

There are dozens of funds to back the ambitious project, which is expected to cost billions of yuan, he said.

"Instead of starting from the R&D stage, Sinobioway is more interested in buying drug patents and firms at home and abroad. Biotech drug production has been very profitable. But starting everything from R&D will be too time-consuming and risky. You may spend years but get nothing."

He said buying patents and firms will bring the company high profits quickly. During the process, it will also develop its own drugs.

This business model has marked the collaboration between Sinobioway and BioAlta, a San Diego-based company focused on the development of Conditionally Active Biologic antibody therapeutics.

In 2015, the two companies forged a strategic collaboration for the development and commercialization of select CAB antibodies and other CAB-based therapeutics in China. "Production of all the drugs will be based in Hefei," said Cao.

BioAlta would receive more than $70 million in payments and investment from Sinobioway in a year, according to their agreement.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 精品毛片免费看 | 国产精品久久久99 | 美女亚洲综合 | 网红主播大尺度精品福利视频 | 欧美日本在线一区二区三区 | 久草视频免费看 | 国产成人精品男人的天堂538 | 亚洲精品国产啊女成拍色拍 | 成人高清无遮挡免费视频软件 | 日本加勒比高清一本大道 | 欧美无玛 | 久久久毛片免费全部播放 | 酒色影院 | 欧美一级在线毛片免费观看 | 亚洲精品一区二区三区福利 | 欧美激情欧美狂野欧美精品免费 | 久久久免费观看视频 | 毛片网站视频 | 国产乱码一区二区三区四 | 亚洲第一成年网站大全亚洲 | 欧美a在线播放 | 精品久久久久久综合日本 | 在线观看免费亚洲 | a级毛片毛片免费很很综合 a级毛片免费 | 成人永久免费视频网站在线观看 | 亚洲高清色 | 亚洲免费色视频 | 亚洲欧美日韩精品在线 | 久草精彩视频 | 久久久久久久久免费影院 | 美女把张开腿男生猛戳免费视频 | 欧美成人综合 | 深夜福利爽爽爽动态图 | 成年午夜性爽快免费视频不卡 | 日本亚州视频在线八a | 亚洲国产精品日韩高清秒播 | 美女视频永久黄网站免费观看韩国 | 麻豆传媒一区 | 99爱免费视频 | 欧美kkk4444在线观看 | 午夜国产高清精品一区免费 |